Cargando…
Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis
Autores principales: | Ferreira, Raphaella D., John, Binu V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363849/ https://www.ncbi.nlm.nih.gov/pubmed/35947303 http://dx.doi.org/10.1007/s10620-022-07644-z |
Ejemplares similares
-
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis
por: John, Binu V., et al.
Publicado: (2022) -
782: COMPARISON OF INFECTION-INDUCED AND VACCINE-INDUCED IMMUNITY AGAINST CORONAVIRUS 2019 IN PATIENTS WITH CIRRHOSIS
por: John, Binu V., et al.
Publicado: (2022) -
The Educational Problem—Victory
Publicado: (1884) -
Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis
por: John, Binu V., et al.
Publicado: (2022) -
Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis
por: John, Binu, et al.
Publicado: (2022)